COVID-19对儿科恶性肿瘤的诊断和治疗的影响：永远不会再一样，但我们学到了许多教训。
The Impact of COVID-19 on Pediatric Malignancy Diagnosis and Treatment: Never the Same but Lessons Learned.
发表日期：2023 Mar 15
作者：
Ghadir K Katato, Prasiksha Sitaula, Avanti Gupte, Eman T Al-Antary
来源：
PEDIATRIC BLOOD & CANCER
摘要：
严重急性呼吸系统综合症冠状病毒2型（SARS-CoV-2）大流行对全球小儿肿瘤学人群产生了影响。在这两年期间，越来越多的报道被提出以更好地了解这种病原体及其对这些患者的病理并发症。这次大流行使医疗保健提供者、医院系统和领先的肿瘤学会迅速适应并制定新的指南，以有效理解、管理和治疗小儿恶性肿瘤患者。
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic affected the pediatric oncology population globally. Over the course of 2 years, increasing reports have been made to better understand this entity and its pathologic complications on these patients. The pandemic has allowed healthcare providers, hospital systems, and leading oncologic societies to quickly adapt and formulate new guidelines for the effective understanding, management, and treatment of patients with pediatric malignancy.